Publications

Advanced microbiome therapeutics as a novel modality for oral delivery of peptides to manage metabolic diseases

 84
Advanced microbiome therapeutics as a novel modality for oral delivery of peptides to manage metabolic diseases

Tags:

Previous Article

Parkinson’s disease pathogenesis from G6PD deficiency

Next Article

Treating metabolic diseases with microbes containing peptides

Related Posts

Vitamin D supplementation ameliorates ductular reaction, liver inflammation and fibrosis in mice by upregulating TXNIP in ductular cells

Vitamin D supplementation ameliorates ductular reaction...

 375

Roles for primary cilia in synapses and neurological disorders

Roles for primary cilia in synapses and neurological di...

 68

Transplacental SARS-CoV-2 protein ORF8 binds to complement C1q to trigger fetal inflammation

Transplacental SARS-CoV-2 protein ORF8 binds to complem...

 79